The cell sorting technology developer has become the first company to be backed by the University of California Riverside-focused VC vehicle Highlander Venture Fund.
The Highlander Venture Fund, a vehicle targeting the University of California (UC) Riverside ecosystem, invested $250,000 into NanoCellect Biomedical, a US-based life science tools spinout from UC San Diego, on Friday.
NanoCellect had previously received $10m in a series B round in November 2017 led by Illumina Ventures, the corporate venturing division of biotech developer Illumina.
Healthcare equipment and services provider Agilent Technologies also took part at the time, contributing cash alongside Anzu Partners, Vertical Venture Partners, FusionX Ventures…
